Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CTRX

Catamaran Corp USA (CTRX) Stock Price, News & Analysis

Catamaran Corp USA logo

About Catamaran Corp USA Stock (NASDAQ:CTRX)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
2.83 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.

Receive CTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catamaran Corp USA and its competitors with MarketBeat's FREE daily newsletter.

CTRX Stock News Headlines

How to start a corporation in 8 easy steps
JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Americas Gold And Silver Corp
Catamaran Stock Hits New 52-Week High (CTRX)
Americas Gold and Silver Corporation (USA.TO)
See More Headlines

CTRX Stock Analysis - Frequently Asked Questions

Catamaran Corp USA (NASDAQ:CTRX) issued its quarterly earnings results on Thursday, February, 26th. The healthcare company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.61 by $0.06. The business's quarterly revenue was up 26.8% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catamaran Corp USA investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Wheaton Precious Metals (WPM) and Vermilion Energy (VET).

Company Calendar

Last Earnings
2/26/2015
Today
11/23/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:CTRX
Previous Symbol
NASDAQ:SXCI
CUSIP
14888710
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:CTRX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners